Requirement of TNFR p75 in ischemia-induced angiogenesis
Requirement of TNFR p75 in ischemia-induced angiogenesis
批准号:
7209312
负责人:
DAVID A. GOUKASSIAN
金额:
$20.91万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-15 至 2009-01-31
关键词:
AdultAgeAgingAngiogenic FactorApoptosisApoptoticAreaArteriesBone MarrowCell AgingCell physiologyCoronaryDataDevelopmentDiseaseEndothelial CellsFailureFibroblast Growth Factor 2Gene ExpressionGene TargetingGenesGoalsHumanIL8 geneImpairmentIn VitroInflammatoryIschemiaLeadLimb structureMediatingMediator of activation proteinModelingMolecularMusPeripheralPeripheral Vascular DiseasesProcessPurposeReceptors, Tumor Necrosis Factor, Type IIRecoveryRecovery of FunctionReportingRisk FactorsRoleSignal TransductionTNF geneTNFRSF1A geneTNFRSF1B geneTestingTissuesTumor Necrosis Factor ReceptorTumor Necrosis Factor-alphaVascular Endothelial CellVascular Endothelial Growth FactorsVascularizationangiogenesiscell agecytokinecytotoxicdesignhuman MPP1 proteinhuman TNF proteinimprovedin vivomacrophagemigrationmonocyteneovascularizationpreventprotective effectresearch studyresponsetranscriptional coactivator p75
中文摘要
描述(由申请人提供):背景:年龄是冠状动脉和外周动脉疾病发展的危险因素。如果血管形成广泛受损,缺血损伤的程度和功能恢复在很大程度上取决于新的侧支血管的发展。肿瘤坏死因子-α是一种巨噬细胞/单核细胞来源的多能介质和促炎细胞因子,在缺血区表达,并有诱导血管生成的报道。已有研究表明,肿瘤坏死因子可通过两种不同的肿瘤坏死因子受体,即肿瘤坏死因子受体1(P55)和肿瘤坏死因子R2(P75),诱导多种血管生成相关基因的表达。在多种血管内皮细胞中,肿瘤坏死因子可促进血管生成因子血管内皮生长因子、碱性成纤维细胞生长因子、IL-8的表达,然而,两种不同的肿瘤坏死因子受体在介导这些反应中的作用尚不清楚。假设:p55在很大程度上介导了肿瘤坏死因子的细胞毒作用,而通过p75的信号转导大多与肿瘤坏死因子-α的保护作用有关,由于衰老与老年人细胞中p55的表达增加和p75的表达减少有关,我们推测p75可能在成人的血管生成信号转导中起重要作用。目的:1)研究肿瘤坏死因子受体p75对血管内皮生长因子和碱性成纤维细胞生长因子基因表达在血管内皮细胞功能和体内血管生成中的作用;肿瘤坏死因子诱导的促血管生成信号和血管生成功能在很大程度上是通过p75TNFR2介导的。2)确定肿瘤坏死因子介导的缺血诱导内皮细胞存活和凋亡信号的分子机制;在缺乏TNFR2 p75的情况下,缺血后的凋亡信号被夸大。3)确定缺血诱导的骨髓内皮祖细胞的动员、迁移和募集在多大程度上依赖于通过p75TNFR2的信号;a)缺血诱导的骨髓内皮祖细胞的动员至少部分是通过TNFR2 p75介导的;b)功能性的TNFR2 p75是骨髓来源的EPC对缺血后恢复的适当贡献所必需的。意义:这项建议的目的是确定缺血诱导的肿瘤坏死因子介导的血管生成信号的某些分子机制,这些信号在成人组织中可能受到损害,部分原因是与年龄相关的TNFR2 p75表达的减少。此外,这一建议可能导致一个基因靶点的确定,该基因靶点可用于改善成人冠状动脉和外周血管疾病中恢复较差的情况,并防止严重的缺血诱导损伤的发展。
英文摘要
DESCRIPTION (provided by applicant): Background: Aging is a risk factor for development of coronary and peripheral artery diseases. The extent of ischemic damage and functional recovery in case of extensive impairment of vascularization is largely depending on the development of new collateral vessels. Tumor necrosis factor alpha (TNF-a), a macrophage/monocyte-derived pluripotent mediator and pro-inflammatory cytokine is expressed in ischemic areas and reported to induce angiogenesis. TNF has been reported to induce the expression of many angiogenesis related genes, through two different TNF receptors, TNFR1 (p55) and TNFR2 (p75). In various vascular ECs, TNF increased the expression of angiogenic factors VEGF, bFGF, IL-8, however, the role of two distinct TNF receptors in mediating these responses are still unclear. Hypothesis: p55 is largely known to mediate cytotoxic effects of TNF, whereas signaling through p75 is mostly implied in protective effects of TNF-alpha and because aging is associated with increased expression of p55 and decreased expression of p75 in cells from aged humans we hypothesized that the p75 may be essential in angiogenic signaling in adults. Purpose: 1) Determine the contribution of TNFR2 p75 on VEGF and bFGF gene expression on EC function in vitro and on angiogenesis in vivo; TNF-induced pro-angiogenic signaling and EC function is mediated, in large part, through p75 TNFR2. 2) Determine molecular mechanisms underlying TNF-mediated ischemia-induced survival and apoptosis signaling in ECs; In the absence of TNFR2 p75 post-ischemic apoptotic signaling is exaggerated. 3) Determine to what extent ischemia-induced mobilization, migration and recruitment of EPCs from bone marrow depends on signaling through p75 TNFR2; a) Ischemia-induced mobilization of EPCs from bone marrow is mediated, at least in part, via TNFR2 p75; b) Functional TNFR2 p75 is necessary for proper contribution of bone marrow-derived EPCs to post-ischemic recovery. Significance: the goal of this proposal is to define certain molecular mechanisms of iscmemia-induced TNF- mediated angiogenic signaling that may be impaired in adult tissue, in part, due to age-associated decrease in TNFR2 p75 expression. In addition, this proposal may lead to an identification of a gene target, which can be used to improve the poor recovery and prevent the development of severe ischemia-induced damage in adult coronary and peripheral vascular diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Requirement of TNFR p75 in ischemia-induced angiogenesis
-
批准号:7351778
-
项目类别:
-
资助金额:$17.08万
-
财政年份:2007
-
负责人:DAVID A. GOUKASSIAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: